Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 37 member 2 (SLC37A2) is an endoplasmic reticulum-associated transporter that functions as a phosphate-linked glucose-6-phosphate (G6P) antiporter, catalyzing the exchange of G6P and inorganic phosphate across membranes[1][2][4][5]. SLC37A2 differs from SLC37A4 (the canonical G6P transporter in gluconeogenic tissues) in that it does not couple to glucose-6-phosphatase and its function is not inhibited by chlorogenic acid[1][2][4]. SLC37A2 is highly expressed in macrophages, spleen, and thymus, with expression markedly upregulated during macrophage differentiation[4]. In bone, SLC37A2 is essential for normal osteoclast function, localizing to lysosome-related organelles involved in bone resorption; knockout in mice results in increased bone mass due to impaired osteoclast activity[3]. Its precise physiological substrate remains incompletely defined, and its role in human disease is under investigation, but it has emerged as a potential therapeutic target for metabolic bone disorders[3][4].
Not established for drugs (no approved inhibitors or modulators).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 37 member 2 (SLC37A2).